In summary, our results indicate a role for FTO in regulating homologous recombination while identifying FTO as a potential therapeutic target to enhance the therapeutic index of RT in HPV– HNSCC treatment. The gene discussed is FTO; the disease is head and neck squamous cell carcinoma.